Cargando…

Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants

INTRODUCTION: Parenteral Nutrition (PN) can lead to intestinal failure associated liver disease (IFALD). There are no human studies to date studying specifically the benefits of light-protection on neonatal IFALD. Recently, the European Medicines Agency and the American Society for Parenteral and En...

Descripción completa

Detalles Bibliográficos
Autores principales: Clauss, Christie, Tack, Valentyna, Macchiarulo, Maria, Akerman, Meredith, El-Chaar, Gladys, Hanna, Nazeeh, Tiozzo, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381878/
https://www.ncbi.nlm.nih.gov/pubmed/35989991
http://dx.doi.org/10.3389/fped.2022.900068
_version_ 1784769173088370688
author Clauss, Christie
Tack, Valentyna
Macchiarulo, Maria
Akerman, Meredith
El-Chaar, Gladys
Hanna, Nazeeh
Tiozzo, Caterina
author_facet Clauss, Christie
Tack, Valentyna
Macchiarulo, Maria
Akerman, Meredith
El-Chaar, Gladys
Hanna, Nazeeh
Tiozzo, Caterina
author_sort Clauss, Christie
collection PubMed
description INTRODUCTION: Parenteral Nutrition (PN) can lead to intestinal failure associated liver disease (IFALD). There are no human studies to date studying specifically the benefits of light-protection on neonatal IFALD. Recently, the European Medicines Agency and the American Society for Parenteral and Enteral Nutrition (ASPEN) both recommended full light protection of PN to reduce the risk of adverse clinical outcomes. OBJECTIVE: The primary objective of this study was to evaluate the impact of light-protecting PN on the incidence of cholestasis and peak direct bilirubin levels in premature infants. STUDY DESIGN: Retrospective chart review of preterm infants requiring PN for a minimum of 2 weeks with or without light-protection. After light protection of the PN solution, primary outcomes (including cholestasis and direct bilirubin levels) of both groups were compared. Secondary outcomes include evaluation of bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), sepsis and mortality. RESULTS: A total of 50 preterm infants <37 weeks gestation were included, 25 infants in each group. There was a statistically significant decrease in the rate of cholestasis (12 vs. 3, p = 0.005), median peak direct bilirubin levels (1.7 vs. 0.9 mg/dL, p = 0.02) and total bilirubin levels (4.1 vs. 3.4, p = 0.05) in the light-protection group compared to no light-protection group. There was a decrease in the incidence of severe BPD (with an increase of mild BPD, resulting in the same overall BPD rate) in the light-protection compared to no light-protection group (7 vs. 15, p = 0.0223). There was no difference in NEC, ROP, sepsis or mortality. CONCLUSION: Our study supports that the practice of light-protecting PN may reduce the incidence of IFALD in premature infants. Moreover, there was a trend toward decreased incidence of severe BPD in the light-protection group. Further light protection studies are needed to confirm these findings.
format Online
Article
Text
id pubmed-9381878
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93818782022-08-18 Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants Clauss, Christie Tack, Valentyna Macchiarulo, Maria Akerman, Meredith El-Chaar, Gladys Hanna, Nazeeh Tiozzo, Caterina Front Pediatr Pediatrics INTRODUCTION: Parenteral Nutrition (PN) can lead to intestinal failure associated liver disease (IFALD). There are no human studies to date studying specifically the benefits of light-protection on neonatal IFALD. Recently, the European Medicines Agency and the American Society for Parenteral and Enteral Nutrition (ASPEN) both recommended full light protection of PN to reduce the risk of adverse clinical outcomes. OBJECTIVE: The primary objective of this study was to evaluate the impact of light-protecting PN on the incidence of cholestasis and peak direct bilirubin levels in premature infants. STUDY DESIGN: Retrospective chart review of preterm infants requiring PN for a minimum of 2 weeks with or without light-protection. After light protection of the PN solution, primary outcomes (including cholestasis and direct bilirubin levels) of both groups were compared. Secondary outcomes include evaluation of bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), sepsis and mortality. RESULTS: A total of 50 preterm infants <37 weeks gestation were included, 25 infants in each group. There was a statistically significant decrease in the rate of cholestasis (12 vs. 3, p = 0.005), median peak direct bilirubin levels (1.7 vs. 0.9 mg/dL, p = 0.02) and total bilirubin levels (4.1 vs. 3.4, p = 0.05) in the light-protection group compared to no light-protection group. There was a decrease in the incidence of severe BPD (with an increase of mild BPD, resulting in the same overall BPD rate) in the light-protection compared to no light-protection group (7 vs. 15, p = 0.0223). There was no difference in NEC, ROP, sepsis or mortality. CONCLUSION: Our study supports that the practice of light-protecting PN may reduce the incidence of IFALD in premature infants. Moreover, there was a trend toward decreased incidence of severe BPD in the light-protection group. Further light protection studies are needed to confirm these findings. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9381878/ /pubmed/35989991 http://dx.doi.org/10.3389/fped.2022.900068 Text en Copyright © 2022 Clauss, Tack, Macchiarulo, Akerman, El-Chaar, Hanna and Tiozzo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Clauss, Christie
Tack, Valentyna
Macchiarulo, Maria
Akerman, Meredith
El-Chaar, Gladys
Hanna, Nazeeh
Tiozzo, Caterina
Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
title Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
title_full Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
title_fullStr Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
title_full_unstemmed Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
title_short Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
title_sort light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381878/
https://www.ncbi.nlm.nih.gov/pubmed/35989991
http://dx.doi.org/10.3389/fped.2022.900068
work_keys_str_mv AT clausschristie lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants
AT tackvalentyna lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants
AT macchiarulomaria lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants
AT akermanmeredith lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants
AT elchaargladys lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants
AT hannanazeeh lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants
AT tiozzocaterina lightprotectionofparenteralnutritioncholestasisandotherprematurityrelatedmorbiditiesinprematureinfants